» Articles » PMID: 33876886

Inflammation-driven Brain and Gut Barrier Dysfunction in Stress and Mood Disorders

Overview
Journal Eur J Neurosci
Specialty Neurology
Date 2021 Apr 20
PMID 33876886
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Regulation of emotions is generally associated exclusively with the brain. However, there is evidence that peripheral systems are also involved in mood, stress vulnerability vs. resilience, and emotion-related memory encoding. Prevalence of stress and mood disorders such as major depression, bipolar disorder, and post-traumatic stress disorder is increasing in our modern societies. Unfortunately, 30%-50% of individuals respond poorly to currently available treatments highlighting the need to further investigate emotion-related biology to gain mechanistic insights that could lead to innovative therapies. Here, we provide an overview of inflammation-related mechanisms involved in mood regulation and stress responses discovered using animal models. If clinical studies are available, we discuss translational value of these findings including limitations. Neuroimmune mechanisms of depression and maladaptive stress responses have been receiving increasing attention, and thus, the first part is centered on inflammation and dysregulation of brain and circulating cytokines in stress and mood disorders. Next, recent studies supporting a role for inflammation-driven leakiness of the blood-brain and gut barriers in emotion regulation and mood are highlighted. Stress-induced exacerbated inflammation fragilizes these barriers which become hyperpermeable through loss of integrity and altered biology. At the gut level, this could be associated with dysbiosis, an imbalance in microbial communities, and alteration of the gut-brain axis which is central to production of mood-related neurotransmitter serotonin. Novel therapeutic approaches such as anti-inflammatory drugs, the fast-acting antidepressant ketamine, and probiotics could directly act on the mechanisms described here improving mood disorder-associated symptomatology. Discovery of biomarkers has been a challenging quest in psychiatry, and we end by listing promising targets worth further investigation.

Citing Articles

Critical Review of the Cross-Links Between Dietary Components, the Gut Microbiome, and Depression.

Randeni N, Xu B Int J Mol Sci. 2025; 26(2).

PMID: 39859327 PMC: 11765984. DOI: 10.3390/ijms26020614.


Protection of Alzheimer's disease progression by a human-origin probiotics cocktail.

Prajapati S, Wang S, Mishra S, Jain S, Yadav H Sci Rep. 2025; 15(1):1589.

PMID: 39794404 PMC: 11724051. DOI: 10.1038/s41598-024-84780-8.


The impact of inflammatory response on psychological status of medical staff during COVID-19 pandemic.

Wang D, Li H, Liu Y, Li H, Liu Y, Hou L Psicol Reflex Crit. 2025; 38(1):3.

PMID: 39757257 PMC: 11700958. DOI: 10.1186/s41155-024-00335-w.


A Comprehensive Review of the Triangular Relationship among Diet-Gut Microbiota-Inflammation.

Randeni N, Bordiga M, Xu B Int J Mol Sci. 2024; 25(17).

PMID: 39273314 PMC: 11394685. DOI: 10.3390/ijms25179366.


Turn off that night light! Light-at-night as a stressor for adolescents.

Guindon G, Murphy C, Milano M, Seggio J Front Neurosci. 2024; 18:1451219.

PMID: 39145296 PMC: 11321986. DOI: 10.3389/fnins.2024.1451219.


References
1.
McKim D, Patterson J, Wohleb E, Jarrett B, Reader B, Godbout J . Sympathetic Release of Splenic Monocytes Promotes Recurring Anxiety Following Repeated Social Defeat. Biol Psychiatry. 2015; 79(10):803-813. PMC: 4728074. DOI: 10.1016/j.biopsych.2015.07.010. View

2.
Camara R, Gander M, Begre S, von Kanel R . Post-traumatic stress in Crohn's disease and its association with disease activity. Frontline Gastroenterol. 2013; 2(1):2-9. PMC: 3854716. DOI: 10.1136/fg.2010.002733. View

3.
Doolin K, Allers K, Pleiner S, Liesener A, Farrell C, Tozzi L . Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes. Psychoneuroendocrinology. 2018; 95:8-17. DOI: 10.1016/j.psyneuen.2018.05.019. View

4.
Kempuraj D, Selvakumar G, Thangavel R, Ahmed M, Zaheer S, Raikwar S . Mast Cell Activation in Brain Injury, Stress, and Post-traumatic Stress Disorder and Alzheimer's Disease Pathogenesis. Front Neurosci. 2018; 11:703. PMC: 5733004. DOI: 10.3389/fnins.2017.00703. View

5.
Zhou Y, Wu F, Wang C, Zheng W, Lan X, Deng X . Relationship between hippocampal volume and inflammatory markers following six infusions of ketamine in major depressive disorder. J Affect Disord. 2020; 276:608-615. DOI: 10.1016/j.jad.2020.06.068. View